Preterm Birth Control Market is Estimated to Grow at a Prime CAGR of 4.9% till 2025 – Integra LifeSciences, Panpac Medical, Personal Medical, Bioteque America
Preterm birth is defined as babies born alive before 37 weeks of pregnancy completion. According to the World Health Organization (WHO), approximately 15 million babies that are victims of preterm birth every years. The identification of women with high risk of preterm birth is a major challenge till date for which various research studies are undergoing at multiple universities, research organizations, and laboratories across the globe. Key factors driving the market are increasing number of preterm births across the world as well as extensive research and development undertaken to bring about new and innovative products.
Increasing initiatives by government and non-government organizations for preterm birth is driving the market for virus filtration over the forecast period
According to a new market research study titled ‘Preterm Birth Control Market - Global Analysis and Forecasts By Treatment Method, the global preterm birth control market is expected to reach US$ 1,809.0 Mn in 2025 from US$ 1,190.5 Mn in 2017. The market is estimated to grow with a CAGR of 4.9% from 2018-2025. The report highlights the trends prevalent in the global preterm birth control market and the factors driving the market along with those that act as deterrents to its growth
Get
Sample Copy at https://www.theinsightpartners.com/sample/TIPMD00002026
Global preterm birth control market, based on the treatment method was
segmented devices and pharmaceutical treatment. In 2017, the pharmaceutical
treatment segment held the largest share of the market, by treatment method and
it is also expected to grow at the fastest rate during the coming years. This
is primarily attributed to its ease of use, lesser side effects, and its
increasing use by the healthcare professionals for preterm birth control.
The market for preterm birth control is expected to grow due to rising number
of preterm births across the globe as well as increasing number of initiatives
undertaken by government and private bodies to promote the use of preterm birth
control therapeutics and devices. In addition, growth of pharmaceutical and
medical device research and development as well as increasing healthcare
expenditure of emerging nations are likely to have a positive impact on the
growth of the preterm birth control market in the coming years.
The major players operating in the preterm birth control market include
CooperSurgical, Inc., MEDGYN PRODUCTS, INC., Integra LifeSciences, Panpac
Medical Corp., Smiths Medical, Thomas Medical, Kangge Medical, Dr. Arabin GmbH
& Co. KG, AMAG Pharmaceuticals, and BEN WAY ENTERPRISES SDN BHD among
others. The market players are focused towards bringing new and innovative
products and services to sustain their position in the market. For instance, in
February 2018, FDA approved Makena a progestin injection by AMAG
Pharmaceuticals for the prevention of preterm birth. Launch of new products and
therapeutics by the manufacturers and distributors of preterm birth control
system are also expected to accelerate the growth of the market.
Browse
Complete Report at https://www.theinsightpartners.com/reports/preterm-birth-control-market
The report segments the global preterm birth control market as follows:
Global Preterm Birth Control Market – By Treatment Method
• Devices
• Cervical Cerclage Devices
• Vaginal Pessaries
• Pharmaceutical Treatment
Global Preterm Birth Control Market – By Geography
• North America
U.S.
Canada
Mexico
• Europe
U.K.
Germany
France
• Asia Pacific (APAC)
Japan
China
India
• Middle East & Africa (MEA)
South Africa
UAE
Saudi Arabia
• South & Central America (SCAM)
Brazil
Buy this Report now at https://www.theinsightpartners.com/buy/TIPMD00002026
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: [email protected]